Montelukast Prescribing at ROTHSCHILD HOUSE GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
3,096
Total Quantity
82.0K
NHS Cost
£4.2K
vs National Avg
+352.2%
ROTHSCHILD HOUSE GROUP prescribed 3,096 items of Montelukast over the last 12 months at a cost of £4,193 to the NHS. This is 352.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
271
Jun 2026
254
Jun 2026
292
Jun 2026
254
Jun 2026
245
Jun 2026
264
Jun 2026
234
Jun 2026
267
Jun 2026
268
Jun 2026
237
Jun 2026
248
Jun 2026
262
Prescribing Details
| Total Items | 3,096 |
|---|---|
| Total Quantity | 82,034 |
| Total NHS Cost | £4,193 |
| Presentations | 4 different forms |
| vs National Average | +352.2% |
Montelukast Prescribing Comparison
| This practice | 3,096 items |
|---|---|
| National average per practice | 685 items |
| Difference | +352.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.